Mineralcorticoid Receptor Antagonist: Even More Evidence - Faiez Zannad

↳ This is a section part of Moment: ISCP 2017 - Treatment of Heart Failure in 2017 - Joint Session ISCP and Cardio Vascular Clinical Trialist forum (I)

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$19.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Mineralcorticoid Receptor Antagonist: Even More Evidence - Presented by Faiez Zannad at ISCP 2017.

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$19.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Cardiologists, interventional Cardiologists
  • Interventional Fellows
  • Interventional Radiologists
  • Vascular Surgeons
  • Emergency Physicians

Learning Objectives

Other Components in this Moment

Overview
Electrolytes and Renal Function in Heart Failure - Celso Amodeo
Raas Dual Inhibition and Beyond in Heart Failure Treatment - Felipe Martínez
The Effect of Coenzyme Qlo on Morbidity and Mortality in Chronic Heart Failure - Krzysztof Filipiak
Antidiabetic Drugs in Management of Heart Failure - The New Revolution? - Xavier Garcia-Moll
Guidelines Update - José Luis López Sendón
Mineralcorticoid Receptor Antagonist: Even More Evidence - Faiez Zannad
Discussion of ISCP 2017 - Treatment of Heart Failure in 2017 - Joint Session ISCP and Cardio Vascular Clinical Trialist forum (I)
Loading Simple Education